Font Size
A
A
A

Lymphoma (cont.)

Outlook

The outlook for HL is very good. It is one of the most curable cancers. The 5-year survival rate after treatment is greater than 80% for adults and greater than 90% for children.

As a result of refinements in and more aggressive approaches to therapy, the outlook for NHL has improved significantly in the last few decades. The 5-year survival rate after treatment is 55% for adults and about 80% for children. The addition of immunotherapy to standard treatment for NHLs may further improve survival rates.

Many people live with lymphoma in remission for many years after treatment. Currently more than 400,000 people in the United States are living with lymphoma.



Next: Support Groups and Counseling »

Printer-Friendly Format  |  Email to a Friend

Women's Health

Find out what women really need.

Are You Depressed? Take the Quiz


Read What Your Physician is Reading on eMedicine

Lymphoma, B-Cell »

Non-Hodgkin lymphoma (NHL) is a heterogenous group of lymphoproliferative malignancies with differing patterns of behavior and responses to treatment (Armitage, 1993).

Read More on eMedicine »

Medical Dictionary